or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho
Predicting outcomes of therapy for prostate carcinoma patients
β Scribed by Michael K. Brawer
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 31 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Clinical research of prostate carcinoma could be enhanced by models that allow early and reliable prediction of outcome. in this study, the authors describe a model-building strategy and compare different models. ## Methods: The sample population was comprised of 158 patients treat
## BACKGROUND. In most reported surgical series, prostate carcinoma patients with a Gleason score of 7 have had worse outcomes than those with other moderately differentiated cancers. Because of variations in reporting grade and grouping Gleason scores, radiation series have conflicting results.
Galectin-1, a member of the beta-galactoside-binding galectin family, is a pleiotropic dimeric protein participating in a variety of normal and pathological processes, including cancer progression. Modulation of the interactions with the basement membrane glycoprotein laminin and induction of apopto